Postoperative Pain Management Market Overview

The report is titled as ‘Postoperative Pain Management Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the postoperative pain management market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. The postoperative pain management market is expected to grow at a significant rate in the near future.

The global postoperative pain management market in 2020 is estimated for more than US$ 32.8 Bn and expected to reach a value of US$ 50.2 Bn by 2028 with a significant CAGR of 5.5%.

Postoperative Pain Management Market Dynamics

The enormous growth in the global population and growing awareness among individuals towards chronic diseases like chronic obstructive pulmonary disorder (COPD) and also towards treatments with surgery in cancer are driving the growth of the global postoperative pain management market. For instance, according to data published by World Health Organization (WHO), in September 2018, Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 Mn deaths in 2018.

In addition, rapid change towards preferences of lifestyles and an increase in the rate of plastic surgery and cosmetic reconstruction is expected to drive the growth of the target market around the globe. Persistent effort towards the innovation and introduction of non-opioid drugs by manufacturers is fueling high competition between manufacturers of postoperative pain management drugs.

Increasing investment of research and development for high-quality post-operative management solutions due to the increasing demand for effectual pain management with minimum side effects, acting as one of the main factors that will drive the growth of the global post-operative pain management market around the globe.

However, complications associated with the overdose of pain management drugs and poor primary health care services in the underdeveloped regions are likely to restraints the growth of the global post-operative pain management market.

Nevertheless, an Increase in the rate of surgical procedures and surgical interventions in various disease conditions are expected to create substantial growth opportunities for the target market around the globe.

Postoperative Pain Management Market Segmentation

The global postoperative pain management market is segmented on the basis of pain type, product, application, target area, and by region.

•    By Pain Type:

    Acute Pain

    Moderate Pain 

    Severe Pain

•    By Product:

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

    Antiepileptic Drugs

    COX-2 Inhibitor

    Opioids

    Other Analgesics

•    By Application

    Cancer Pain 

    Arthritic Pain 

    Neuropathic Pain 

    Musculoskeletal Pain

    Migraine

•    By Target Area:

    Back

    Legs

    Hand And Arms

    Other

•    By Region:

    North America

    Europe

    Asia Pacific

    Latin America

    Middle East

    Africa

Postoperative Pain Management Market Drug Pipeline Overview

Many of the top companies are launching new and novel drug treatments to increase their market for postoperative pain management. Because of the side effects and habit-forming property of the therapy major players are concentrating on the development of better analgesics. Companies are using a trend of strategic alliance and acquisition to gain the global market and minimize the competition in the global postoperative pain management market.

Postoperative Pain Management Market Competitive Landscape

Some of the key participating players in the global postoperative pain management market are Teva Pharmaceutical Industries Ltd., Novartis AG, Allergan plc, Mylan N.V., Pfizer Inc., Purdue Pharma L.P, Janssen Pharmaceuticals, Inc., Endo International plc, Pacira Pharmaceuticals Inc., Egalet Corporation., and GlaxoSmithKline Plc.

Regional Segmentation

On the basis of region, the postoperative pain management market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

MMC Overview on Postoperative Pain Management Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Postoperative Pain Management market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth include (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Postoperative Pain Management

•    Advantages of Postoperative Pain Management

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Postoperative Pain Management Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Postoperative Pain Management Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Postoperative Pain Management Market Snapshot

2.4.    Global Postoperative Pain Management Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Postoperative Pain Management Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Postoperative Pain Management Market, By Product

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Product

3.1.2.    BPS Analysis, By Product

3.2.    Market Revenue (US$Mn) Forecast, By Product

3.2.1.    Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

3.2.2.    Antiepileptic Drugs

3.2.3.    COX-2 Inhibitor

3.2.4.    Opioids

3.2.5.    Other Analgesics

3.3.    Global Postoperative Pain Management Market Attractiveness Index, By Product

4.    Global Postoperative Pain Management Market, By Pain Type

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Pain Type

4.1.2.    BPS Analysis, By Pain Type

4.2.    Market Revenue (US$Mn) Forecast, By Pain Type

4.2.1.    Acute Pain

4.2.2.    Moderate Pain 

4.2.3.    Severe Pain

4.3.    Global Postoperative Pain Management Market Attractiveness Index, By Pain Type

5.    Global Postoperative Pain Management Market, By Application

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Application

5.1.2.    BPS Analysis, By Application

5.2.    Market Revenue (US$Mn) Forecast, By Application

5.2.1.    Cancer Pain

5.2.2.    Arthritic Pain

5.2.3.    Neuropathic Pain

5.2.4.    Musculoskeletal Pain

5.2.5.    Migraine

5.3.    Global Postoperative Pain Management Market Attractiveness Index, By Application

6.    Global Postoperative Pain Management Market, By Target Area

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Target Area

6.1.2.    BPS Analysis, By Target Area

6.2.    Market Revenue (US$Mn) Forecast, By Target Area

6.2.1.    Back

6.2.2.    Legs

6.2.3.    Hand And Arms

6.2.4.    Other

6.3.    Global Postoperative Pain Management Market Attractiveness Index, By Target Area

7.    Global Postoperative Pain Management Market, By Region

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Region

7.1.2.    BPS Analysis, By Region

7.2.    Market Revenue (US$Mn) Forecast, By Region

7.2.1.    North America

7.2.2.    Latin America

7.2.3.    Europe

7.2.4.    Asia Pacific

7.2.5.    Middle East

7.2.6.    Africa

7.3.    Global Postoperative Pain Management Market Attractiveness Index, By Region

8.    North America Postoperative Pain Management Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market Revenue (US$Mn) Forecast, By Country

8.2.1.    U.S. Postoperative Pain Management Market

8.2.2.    Canada Postoperative Pain Management Market

8.3.    North America Postoperative Pain Management Market, By Product

8.3.1.    Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

8.3.2.    Antiepileptic Drugs

8.3.3.    COX-2 Inhibitor

8.3.4.    Opioids

8.3.5.    Other Analgesics

8.4.    North America Postoperative Pain Management Market, By Pain Type

8.4.1.    Acute Pain

8.4.2.    Moderate Pain 

8.4.3.    Severe Pain

8.5.    North America Postoperative Pain Management Market, By Application

8.5.1.    Cancer Pain

8.5.2.    Arthritic Pain

8.5.3.    Neuropathic Pain

8.5.4.    Musculoskeletal Pain

8.5.5.    Migraine

8.6.    North America Postoperative Pain Management Market, By Target Area

8.6.1.    Back

8.6.2.    Legs

8.6.3.    Hand And Arms

8.6.4.    Other

8.7.    North America Postoperative Pain Management Market Attractiveness Index

8.7.1.    By Country

8.7.2.    By Product

8.7.3.    By Pain Type

8.7.4.    By Application

8.7.5.    By Target Area

9.    Latin America Postoperative Pain Management Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    Brazil Postoperative Pain Management Market

9.2.2.    Mexico Postoperative Pain Management Market

9.2.3.    Argentina Postoperative Pain Management Market

9.2.4.    Rest of Latin America Postoperative Pain Management Market

9.3.    Latin America Postoperative Pain Management Market, By Product

9.3.1.    Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

9.3.2.    Antiepileptic Drugs

9.3.3.    COX-2 Inhibitor

9.3.4.    Opioids

9.3.5.    Other Analgesics

9.4.    Latin America Postoperative Pain Management Market, By Pain Type

9.4.1.    Acute Pain

9.4.2.    Moderate Pain 

9.4.3.    Severe Pain

9.5.    Latin America Postoperative Pain Management Market, By Application

9.5.1.    Cancer Pain

9.5.2.    Arthritic Pain

9.5.3.    Neuropathic Pain

9.5.4.    Musculoskeletal Pain

9.5.5.    Migraine

9.6.    Latin America Postoperative Pain Management Market, By Target Area

9.6.1.    Back

9.6.2.    Legs

9.6.3.    Hand And Arms

9.6.4.    Other

9.7.    Latin America Postoperative Pain Management Market Attractiveness Index

9.7.1.    By Country

9.7.2.    By Product

9.7.3.    By Pain Type

9.7.4.    By Application

9.7.5.    By Target Area

10.    Europe Postoperative Pain Management Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    U.K. Postoperative Pain Management Market

10.2.2.    Germany Postoperative Pain Management Market

10.2.3.    Italy Postoperative Pain Management Market

10.2.4.    France Postoperative Pain Management Market

10.2.5.    Spain Postoperative Pain Management Market

10.2.6.    Russia Postoperative Pain Management Market

10.2.7.    Poland Postoperative Pain Management Market

10.2.8.    BENELUX Postoperative Pain Management Market

10.2.9.    NORDIC Postoperative Pain Management Market

10.2.10.    Rest of Europe Postoperative Pain Management Market

10.3.    Europe Postoperative Pain Management Market, By Product

10.3.1.    Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

10.3.2.    Antiepileptic Drugs

10.3.3.    COX-2 Inhibitor

10.3.4.    Opioids

10.3.5.    Other Analgesics

10.4.    Europe Postoperative Pain Management Market, By Pain Type

10.4.1.    Acute Pain

10.4.2.    Moderate Pain 

10.4.3.    Severe Pain

10.5.    Europe Postoperative Pain Management Market, By Application

10.5.1.    Cancer Pain

10.5.2.    Arthritic Pain

10.5.3.    Neuropathic Pain

10.5.4.    Musculoskeletal Pain

10.5.5.    Migraine

10.6.    Europe Postoperative Pain Management Market, By Target Area

10.6.1.    Back

10.6.2.    Legs

10.6.3.    Hand And Arms

10.6.4.    Other

10.7.    Europe Postoperative Pain Management Market Attractiveness Index

10.7.1.    By Country

10.7.2.    By Product

10.7.3.    By Pain Type

10.7.4.    By Application

10.7.5.    By Target Area

11.    Asia Pacific Postoperative Pain Management Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    China Postoperative Pain Management Market

11.2.2.    India Postoperative Pain Management Market

11.2.3.    Japan Postoperative Pain Management Market

11.2.4.    Australia and New Zealand Postoperative Pain Management Market

11.2.5.    South Korea Postoperative Pain Management Market

11.2.6.    ASEAN Postoperative Pain Management Market

11.2.7.    Rest of Asia Pacific Postoperative Pain Management Market

11.3.    Asia Pacific Postoperative Pain Management Market, By Product

11.3.1.    Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

11.3.2.    Antiepileptic Drugs

11.3.3.    COX-2 Inhibitor

11.3.4.    Opioids

11.3.5.    Other Analgesics

11.4.    Asia Pacific Postoperative Pain Management Market, By Pain Type

11.4.1.    Acute Pain

11.4.2.    Moderate Pain 

11.4.3.    Severe Pain

11.5.    Asia Pacific Postoperative Pain Management Market, By Application

11.5.1.    Cancer Pain

11.5.2.    Arthritic Pain

11.5.3.    Neuropathic Pain

11.5.4.    Musculoskeletal Pain

11.5.5.    Migraine

11.6.    Asia Pacific Postoperative Pain Management Market, By Target Area

11.6.1.    Back

11.6.2.    Legs

11.6.3.    Hand And Arms

11.6.4.    Other

11.7.    Asia Pacific Postoperative Pain Management Market Attractiveness Index

11.7.1.    By Country

11.7.2.    By Product

11.7.3.    By Pain Type

11.7.4.    By Application

11.7.5.    By Target Area

12.    Middle East Postoperative Pain Management Market, By Region

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    GCC Countries Postoperative Pain Management Market

12.2.2.    Israel Postoperative Pain Management Market

12.2.3.    Oman Postoperative Pain Management Market

12.2.4.    Rest of Middle East Postoperative Pain Management Market

12.3.    Middle East Postoperative Pain Management Market, By Product

12.3.1.    Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

12.3.2.    Antiepileptic Drugs

12.3.3.    COX-2 Inhibitor

12.3.4.    Opioids

12.3.5.    Other Analgesics

12.4.    Middle East Postoperative Pain Management Market, By Pain Type

12.4.1.    Acute Pain

12.4.2.    Moderate Pain 

12.4.3.    Severe Pain

12.5.    Middle East Postoperative Pain Management Market, By Application

12.5.1.    Cancer Pain

12.5.2.    Arthritic Pain

12.5.3.    Neuropathic Pain

12.5.4.    Musculoskeletal Pain

12.5.5.    Migraine

12.6.    Middle East Postoperative Pain Management Market, By Target Area

12.6.1.    Back

12.6.2.    Legs

12.6.3.    Hand And Arms

12.6.4.    Other

12.7.    Middle East Postoperative Pain Management Market Attractiveness Index

12.7.1.    By Country

12.7.2.    By Product

12.7.3.    By Pain Type

12.7.4.    By Application

12.7.5.    By Target Area

13.    Africa Postoperative Pain Management Market, By Region

13.1.    Introduction

13.1.1.    Annual Growth Rate Comparison, By Country

13.1.2.    BPS Analysis, By Country

13.2.    Market (US$Mn) Forecast, By Country

13.2.1.    South Africa Postoperative Pain Management Market

13.2.2.    Egypt Postoperative Pain Management Market

13.2.3.    North Africa Postoperative Pain Management Market

13.2.4.    Rest of Africa Postoperative Pain Management Market

13.3.    Africa Postoperative Pain Management Market, By Product

13.3.1.    Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)

13.3.2.    Antiepileptic Drugs

13.3.3.    COX-2 Inhibitor

13.3.4.    Opioids

13.3.5.    Other Analgesics

13.4.    Africa Postoperative Pain Management Market, By Pain Type

13.4.1.    Acute Pain

13.4.2.    Moderate Pain 

13.4.3.    Severe Pain

13.5.    Africa Postoperative Pain Management Market, By Application

13.5.1.    Cancer Pain

13.5.2.    Arthritic Pain

13.5.3.    Neuropathic Pain

13.5.4.    Musculoskeletal Pain

13.5.5.    Migraine

13.6.    Africa Postoperative Pain Management Market, By Target Area

13.6.1.    Back

13.6.2.    Legs

13.6.3.    Hand And Arms

13.6.4.    Other

13.7.    Africa Postoperative Pain Management Market Attractiveness Index

13.7.1.    By Country

13.7.2.    By Product

13.7.3.    By Pain Type

13.7.4.    By Application

13.7.5.    By Target Area

14.    Recommendation

14.1.    Market Strategy

15.    Competitive Landscape

15.1.    Competition Dashboard

15.2.    List and Company Overview of Global Key Players

15.3.    Company Profiles

15.3.1.    Teva Pharmaceutical Industries Ltd.

15.3.1.1.    Company Overview

15.3.1.2.    Financial Overview

15.3.1.3.    Component Portfolio

15.3.1.4.    Key Developments

15.3.1.5.    Business Strategies

15.3.2.    Novartis AG

15.3.3.    Allergan plc

15.3.4.    Mylan N.V.

15.3.5.    Pfizer Inc.

15.3.6.    Purdue Pharma L.P

15.3.7.    Janssen Pharmaceuticals, Inc.

15.3.8.    Endo International plc

15.3.9.    Pacira Pharmaceuticals Inc.

15.3.10.   Egalet Corporation

15.3.11.    GlaxoSmithKline Plc.

16.    Acronyms